Intelligent Bio Solutions Inc. - Common Stock INBS 深 沪
已收盘 08-29 16:00:00 美东时间
1.62
-0.030
-1.82%
华盛通- 最 高1.69
- 今 开1.68
- 成交量 11.90万股
- 最 低 1.5582
- 昨 收 1.65
- 总市值 1414.97万
- 52周最高 3.00
- 市盈率 静 --
- 换手率 1.36%
- 52周最低 1.10
- 委 比 -11.84%
- 总股本 873.44万
- 历史最高 3417.60
- 量 比 0.77
- 振 幅 7.99%
- 历史最低 1.10
- 每 手 1
- 风险率 1.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
Intelligent Bio Solutions Inc. (INBS) reported record cartridge sales in July 2025, with 519 boxes shipped, representing over 12,500 cartridges and a 60% year-on-year increase. This growth reflects the strength of the company's razor/razor blade business model, driven by new contracts and expanding global installed base. A major transportation sector tender win and increased demand for consumables contributed to the surge. CEO Harry Simeonidis hi...
08-19 12:30
Intelligent Bio Solutions Q4 EPS $(0.36), Sales $843.884K Up From $727.824K YoY
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.36) per share. The company reported $843.884 thousand in sales this quarter. This is a 15.95 percent increase over sales of $727.824 thousand the
08-15 20:41
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
Intelligent Bio Solutions Inc. reported a 16% revenue growth in Q4 2025, driven by increased demand for drug testing cartridges. The company advanced efforts to secure U.S. FDA 510(k) clearance for its opiate test system, aiming to expand beyond Forensic Use Only settings. Fiscal 2025 marked higher-margin cartridge sales and operational improvements, with a customer base exceeding 450 accounts across 24 countries. Expansion efforts continue in Ca...
08-15 12:30
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
Intelligent Bio Solutions Inc. announced that its management team will participate in the Sidoti Micro-Cap Virtual Conference on August 21, 2025, at 9:15 a.m. ET. The Company, which specializes in rapid, non-invasive drug testing solutions, will discuss its Intelligent Fingerprinting Drug Screening System, designed for workplace safety. To learn more or schedule a meeting, contact Sidoti or KCSA Strategic Communications. Visit http://www.ibs.inc ...
08-12 12:30
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
Intelligent Bio Solutions Inc. expects a 16% sequential and year-over-year revenue growth in its fiscal fourth quarter ended June 30, 2025, driven by higher-margin cartridge sales and account growth. The company submitted an FDA 510(k) application for its opiate test system, upgraded its drug screening system for global adoption, and launched localized websites and CRM enhancements in Europe, the Middle East, and Latin America. Preliminary result...
08-07 12:30
Intelligent Bio Solutions Submits Key FDA Information
Intelligent Bio Solutions ( ($INBS) ) has shared an announcement. On August 6, ...
08-06 21:50
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch
Intelligent Bio Solutions Inc. (INBS) submitted additional information to the FDA as part of its 510(k) clearance process for market entry later this year. The submission includes new data from cybersecurity and electromagnetic compatibility testing, totaling over 1900 pages and reinforcing the security and performance of its fingerprint sweat-based drug screening technology. INBS has also validated its technology's accuracy using advanced quanti...
08-06 12:30
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
Intelligent Bio Solutions Inc. (INBS) has secured a major contract with a leading public transport operator in London to deploy its Intelligent Fingerprinting Drug Screening System across 14 operational sites. The system, which provides rapid, non-invasive drug testing, aims to enhance workforce efficiency and safety. INBS, a medical technology company, has over 450 accounts in 24 countries and plans to expand further globally, including a focus ...
07-30 12:30
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
Intelligent Bio Solutions Inc. announces an agreement with certain warrant holders to exercise or prepay existing warrants to purchase up to 2,023,228 shares at $1.90 per share, generating approximately $3.8 million in gross proceeds. The Company plans to use the funds to complete its 510k filing with the U.S. FDA for its Fingerprint Drug Screening System and for general corporate purposes. Additionally, exercising holders will receive new warran...
07-25 12:30
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
Intelligent Bio strengthens its FDA 510(k) submission with new data, cybersecurity tests, and advanced fingerprint sweat analysis technology.
07-23 20:03
